Applied DNA Sciences Inc. (APDN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.19
0.01 (4.11%)
At close: Jan 15, 2025, 9:53 AM
Applied DNA Sciences Inc. Revenue Breakdown
Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asset Marking Revenue | 0 | 9.44K | 9.44K | 39.03K | 92.31K | 97.34K | 83.13K | 113.72K | 140.17K | 151.76K | 97.23K | 83.53K | 110.70K | 108.57K | 117.98K | 140.56K | 158.08K | 161.05K |
Asset Marking Revenue Growth | -100.00% | 0.00% | -75.81% | -57.72% | -5.17% | +17.10% | -26.90% | -18.87% | -7.64% | +56.08% | +16.40% | -24.54% | +1.96% | -7.97% | -16.07% | -11.08% | -1.84% | n/a |
Clinical Laboratory Testing Services (Over-Time) Revenue | 636.16K | 324.58K | 324.58K | 509.11K | 653.38K | 938.08K | 1.44M | 23.95K | 67.06K | 32.94K | 2.90K | 4.36K | 12.65K | 18.67K | 1.03M | 161.93K | 20.23K | 250.10K |
Clinical Laboratory Testing Services (Over-Time) Revenue Growth | +95.99% | 0.00% | -36.25% | -22.08% | -30.35% | -34.85% | +5912.78% | -64.29% | +103.56% | +1036.32% | -33.48% | -65.54% | -32.28% | -98.19% | +537.06% | +700.27% | -91.91% | n/a |
Clinical Laboratory Testing Services (Point-in-Time) Revenue | 14.05K | 6.44K | 12.12K | 14.22K | 1.52M | 3.00M | 3.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Clinical Laboratory Testing Services (Point-in-Time) Revenue Growth | +118.17% | -46.86% | -14.79% | -99.07% | -49.34% | -2.32% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Large Scale DNA Production Revenue | 325.96K | 258.15K | 77.53K | 0 | 271.88K | 253.63K | 127.51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Large Scale DNA Production Revenue Growth | +26.27% | +232.95% | n/a | -100.00% | +7.20% | +98.91% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Services (Over-Time) Revenue | 168.50K | 65.20K | 467.49K | 72.00K | 135.62K | 87.91K | 126.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Services (Over-Time) Revenue Growth | +158.44% | -86.05% | +549.31% | -46.91% | +54.28% | -30.26% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Supply Chain Revenue | 465.95K | 275.26K | n/a | 145.38K | 242.83K | 27.64K | 411.76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Supply Chain Revenue Growth | +69.28% | n/a | n/a | -40.13% | +778.66% | -93.29% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 |
---|---|---|---|---|---|---|---|---|---|
Americas Revenue | 2.27M | 12.22M | 17.54M | 147.89K | 266.70K | 600.37K | 1.00M | 1.06M | 876.79K |
Americas Revenue Growth | -81.43% | -30.33% | +11762.93% | -44.55% | -55.58% | -40.23% | -4.80% | +20.34% | n/a |
Asia And Other Revenue | 989.23K | 886.44K | 175.39K | 359.51K | n/a | n/a | n/a | n/a | n/a |
Asia And Other Revenue Growth | +11.60% | +405.42% | -51.22% | n/a | n/a | n/a | n/a | n/a | n/a |
Europe Revenue | 172.37K | 258.36K | 448.85K | n/a | n/a | n/a | n/a | n/a | n/a |
Europe Revenue Growth | -33.28% | -42.44% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.68M | 2.68M | 3.00M | 3.08M | 3.31M | 3.29M | 3.52M | 2.63M | 3.87M | 3.01M | 3.41M | 4.66M | 2.31M | 3.24M | 3.56M | 3.50M | 2.89M | 2.59M | 2.29M | 2.37M | 2.26M | 2.41M | 2.53M | 3.08M | 3.57M | 2.88M | 2.00M | 2.59M | 2.79M | 3.40M | 3.23M | 3.90M | 2.62M | 2.71M | 3.12M | 3.55M | 3.66M | 3.51M | 2.90M |
Selling, General, and Administrative Revenue Growth | +0.21% | -10.71% | -2.73% | -6.84% | +0.57% | -6.54% | +34.18% | -32.22% | +28.51% | -11.69% | -26.80% | +101.63% | -28.63% | -8.93% | +1.62% | +21.13% | +11.63% | +13.28% | -3.70% | +5.04% | -6.14% | -4.81% | -17.96% | -13.70% | +23.92% | +44.35% | -23.00% | -7.07% | -18.00% | +5.34% | -17.19% | +48.71% | -3.11% | -13.24% | -12.21% | -2.83% | +4.26% | +20.93% | n/a |
Research and Development Revenue | 831.71K | 913.03K | 726.87K | 935.82K | 938.91K | 836.12K | 988.74K | 971.30K | 912.88K | 863.02K | 1.07M | 1.08M | 1.11M | 1.03M | 874.05K | 748.37K | 1.24M | 814.60K | 703.02K | 564.43K | 886.67K | 719.67K | 651.38K | 709.56K | 716.69K | 625.01K | 669.81K | 740.07K | 524.75K | 603.10K | 635.89K | 518.63K | 832.23K | 1.08M | 729.08K | 471.93K | 673.64K | 310.09K | 373.38K |
Research and Development Revenue Growth | -8.91% | +25.61% | -22.33% | -0.33% | +12.29% | -15.44% | +1.80% | +6.40% | +5.78% | -19.35% | -0.93% | -2.99% | +8.14% | +17.80% | +16.80% | -39.63% | +52.19% | +15.87% | +24.55% | -36.34% | +23.21% | +10.48% | -8.20% | -0.99% | +14.67% | -6.69% | -9.49% | +41.03% | -12.99% | -5.16% | +22.61% | -37.68% | -22.79% | +47.85% | +54.49% | -29.94% | +117.24% | -16.95% | n/a |